Skip to main content
WeightCited

Menopause-Related Weight Gain
Menopause-Related Weight Gain

Prävalenz: Affects the majority of menopausal women; average age of menopause: 51 years; 1.3 million US women enter menopause annually

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'condition\u003Dmenopause\u002Dweight'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Evidence-Ranked Ingredients

Inhaltsstoff Bewertung Studien Richtung
Vitamin D C 6 Positive Ansehen →
Maca C 5 Positive Ansehen →

About

{# Filter order is load-bearing: escape (untrusted text) -> linebreaks (paragraphs) -> paper anchors (internal /papers/ links) -> glossary (never links inside an existing ). #}

Menopause arrives at an average age of 51, and roughly 1.3 million women in the United States reach it each year. The weight change accompanying the transition is less a matter of total mass than of distribution: declining estrogen shifts fat storage from the hips and thighs toward the abdomen, so waist circumference can increase while the total gain stays modest, averaging about 2.3 kilograms across the transition. Aging, reduced physical activity, and disrupted sleep compound the effect. Two ingredients hold grades against this condition here, both at Grade C, on 11 studies and 800 participants.

Vitamin D carries Grade C on 6 studies and 500 participants. Its study base in menopause is broader than its weight-specific base, and it has been examined within multi-component formulations combining soy isoflavones, lactobacilli, magnolia bark extract, vitamin D3, and calcium in controlled clinical work [1]. A systematic review has assessed nutritional status and supplementation across vitamin complexes and iron in this population [2].

Maca holds the same grade on 5 studies and 300 participants, studied principally for vasomotor and mood symptoms rather than for body composition. Its inclusion reflects the pattern of the whole field: supplement research in menopause concentrates on symptom relief and on skeletal endpoints rather than on weight. A randomized placebo-controlled trial of resveratrol, for instance, reported improved bone mineral density in postmenopausal women [3], an outcome of genuine importance that says nothing about adiposity. Broader phytocomplex work has likewise measured well-being in climacteric women rather than weight [4].

The best-documented intervention for the metabolic changes of this period is not nutritional. A three-year controlled study of exercise in early postmenopausal women examined effects across menopausal risk factors including bone density and metabolic markers [5]. Resistance training addresses the lean-mass loss accompanying the transition, and lean mass is the principal determinant of the resting energy expenditure against which weight is maintained.

Three limits apply. The trials in this set are small, 300 to 500 participants per ingredient, and short relative to a transition measured in years. Menopausal weight change is confounded with chronological aging, and few designs separate the two. And symptom overlap is substantial: hot flashes, sleep disruption, mood change, and decreasing bone density accompany the weight change and are the endpoints most trials actually measure. Hormone therapy and its alternatives are clinical decisions outside the scope of a supplement grading, and vitamin D dosing should follow measured status.

Common Symptoms

Weight gain (especially abdominal) Hot flashes Sleep disruption Mood changes Decreased muscle mass Increased visceral fat Decreased bone density

Risk Factors

  • Estrogen decline
  • Aging-related metabolic slowdown
  • Sleep disruption
  • Reduced physical activity
  • Stress
  • Genetic predisposition

Frequently Asked Questions

What supplements are studied for Menopause-Related Weight Gain?
Research has examined 2 supplement ingredients for Menopause-Related Weight Gain, including Vitamin D. Evidence strength varies; review individual grades for details.
How is the evidence for Menopause-Related Weight Gain supplements graded?
We grade supplements on an A-F scale based on clinical study quality, consistency of results, sample sizes, and study design. Grade A indicates strong evidence from multiple clinical trials, while Grade D indicates preliminary evidence requiring further research.
How many studies on Menopause-Related Weight Gain supplements have been reviewed?
Our evidence grades for Menopause-Related Weight Gain are based on a total of 11 peer-reviewed studies across 2 ingredients. Studies are sourced from PubMed and include randomized controlled trials, meta-analyses, and other clinical research.
What are common symptoms of Menopause-Related Weight Gain?
Common symptoms associated with Menopause-Related Weight Gain include Weight gain (especially abdominal), Hot flashes, Sleep disruption, Mood changes, Decreased muscle mass. If you are experiencing these symptoms, consult a healthcare professional for proper diagnosis and treatment options.

References

  1. 1. Soy isoflavones, lactobacilli, Magnolia bark extract, vitamin D3 and calcium. Controlled clinical study in menopause. Minerva ginecologica, 2006 PMID 16957676
  2. 2. A systematic review on the impact of nutrition and possible supplementation on the deficiency of vitamin complexes, iron, omega-3-fatty acids, and lycopene in relation to increased morbidity in women after menopause. Archives of gynecology and obstetrics, 2024 PMID 38935105
  3. 3. Regular Supplementation With Resveratrol Improves Bone Mineral Density in Postmenopausal Women: A Randomized, Placebo-Controlled Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2020 PMID 32564438
  4. 4. Effects of a phyto complex on well-being of climacteric women. The journal of obstetrics and gynaecology research, 2015 PMID 25656636
  5. 5. Exercise effects on menopausal risk factors of early postmenopausal women: 3-yr Erlangen fitness osteoporosis prevention study results. Medicine and science in sports and exercise, 2005 PMID 15692313

Beschwerden mit gemeinsamen untersuchten Inhaltsstoffen

FDA-Haftungsausschluss: Diese Aussagen wurden nicht von der Food and Drug Administration bewertet. Die Produkte und Informationen auf dieser Website sind nicht dazu bestimmt, Krankheiten zu diagnostizieren, zu behandeln, zu heilen oder zu verhindern. Die dargestellten Evidenzbewertungen basieren auf unserer Analyse veröffentlichter begutachteter Forschung und stellen keine medizinische Beratung dar. Konsultieren Sie immer Ihren Arzt, bevor Sie mit der Einnahme von Nahrungsergänzungsmitteln beginnen.